Skip to main content
. 2015 Dec 15;13(4):659. doi: 10.18549/PharmPract.2015.04.659

Table 5.

Strata of high complexity and characteristics of PHC in adult patients attending a mid-sized city of Minas Gerais, 2012

Characteristic % (n) High Complexity
MRCI ≥25.4 MRCI ≥20.9 MRCI ≥17.5 MRCI ≥15.7 MRCI ≥14.0 MRCI ≥13.0
Number of patients 9 18 35 54 69 82
Female 77.8 (7) 83.3 (15) 80.0 (32) 81.5 (44) 78.7 (59) 78.5 (73)
Studied for up to 8 years 77.8 (7) 72.2 (13) 67.5 (27) 68.6 (37) 64.0 (48) 65.6 (61)
Number of clinical conditions1 6.0 (4.5;6.0) 4.5(3.8;6.0) 4.0(3.0;5.0) 4.0 (3.0;5.0) 4.0 (3.0;5.0) 3.0 (3.0;4.0)
Cardiovascular disease1 1.0 (1.0;1.0) 1.0 (1.0;1.0) 1.0 (1.0;1.0) 1.0 (1.0;1.0) 1.0 (1.0;1.0) 1.0 (1.0;1.0)
Endocrine metabolic disease1 2.0 (1.0; 3.0) 2.0 (1.5; 2.0) 2.0 (1.0; 2.0) 2.0 (1.0; 2.0) 2.0 (1.0;2.0) 2.0 (1.0;2.0)
Number of medical appointments per year1 3.0 (2.0;5.8) 2.0 (2.0;3.5) 3.0 (2.0;5.0) 3.0 (2.0;6.0) 3.0 (2.0;6.0) 3.0 (2.0;6.0)
Number of drugs1 10.0 (9.0;11.5) 8.0 (7.0;10.0) 6.5 (5.3;8.0) 6.0 (5.0;8.0) 6.0 (5.0;7.0) 5.0 (4.0;7.0)
Polypharmacy 100 (9) 100 (18) 87.5 (35) 87.0 (47) 78.7 (59) 74.2 (69)
All medicines were accessed by PHS 55.6 (5) 72.7 (13) 80.0 (32) 75.9 (41) 80.0 (60) 80.6 (75)
Has at least one PDRP 100 (9) 94.4 (17) 80.0 (32) 81.5 (44) 84.0 (63) 78.5 (73)
Adherence 44.4 (4) 61.1 (11) 72.5 (29) 72.2 (39) 70.7 (53) 72.0 (67)
1

Median (Percentile 25; Percentile 75)